Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06418178

Dose Optimization of MDMA-Assisted Therapy for PTSD

Led by Bronx VA Medical Center · Updated on 2025-06-26

60

Participants Needed

1

Research Sites

225 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This open label, within-subjects dose optimization trial will investigate the optimal number of MDMA-Assisted Therapy treatment cycles (i.e., one MDMA session and three integration sessions) in a sample of U.S. veterans with PTSD. Participants will complete from one to five cycles of MDMA-AT.

CONDITIONS

Official Title

Dose Optimization of MDMA-Assisted Therapy for PTSD

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Are a U.S. military veteran at least 18 years old.
  • Are able to provide written, informed consent.
  • Are able to swallow pills.
  • Agree to have study visits recorded, including Experimental Sessions, psychological assessments, and non-drug therapy sessions.
  • Must provide a contact who is willing and able to be reached by the investigators in the event of a participant becoming unwell or unreachable.
  • If able to become pregnant, must have a negative pregnancy test at study entry and prior to each Experimental Session, and must agree to use adequate contraceptive methods.
  • Must have a current PTSD diagnosis at screening and baseline.
  • Must not participate in any other interventional clinical trials for the duration of the study.
  • Must commit to medication dosing, therapy, and all study procedures.
Not Eligible

You will not qualify if you...

  • Are not able to give adequate informed consent.
  • Have a history of any medical condition, or any significant clinical finding on screening tests, that could make receiving a sympathomimetic drug harmful.
  • Have uncontrolled hypertension.
  • Have evidence or history of significant medical or psychiatric disorders.
  • Have symptomatic liver disease.
  • Have history of hyponatremia or hyperthermia.
  • Weigh less than 48 kilograms (kg).
  • Unable or unwilling to safely taper off prohibited psychiatric medication.
  • Abusing illegal drugs or alcohol.
  • Have received Electroconvulsive Therapy (ECT) or ketamine therapy within 12 weeks of enrollment.
  • Are pregnant or nursing or are able to become pregnant and are not practicing an effective means of contraception.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

James J. Peters VA Medical Center

The Bronx, New York, United States, 10468

Actively Recruiting

Loading map...

Research Team

A

Amy Lehrner, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here